Physician profile
Linda Ding
NPI 1902123094
$6,055.53
in general payments reported to CMS, 2019-2025
15 companies · $5,060 in 2025
The $5,060 reported for 2025 was more than what 89% of Trauma Surgery providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $435 · 2020: $457 · 2023: $63.15 · 2024: $40.50 · 2025: $5,060.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,205 · Travel and Lodging: $834 · Food and Beverage: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,204.95 |
| Travel and Lodging | $834.30 |
| Food and Beverage | $124.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,242.96 | 2019-2025 | |
| Kci USA, INC. | $196.73 | 2020 | |
| W. L. Gore & Associates, INC. | $171.52 | 2020 | |
| Ethicon US, LLC | $152.08 | 2019-2024 | Evarrest, Harmonic, Surgicel Nu-Knit |
| Tela Bio, INC. | $75.43 | 2019 | |
| Polarityte, INC. | $60.83 | 2019 | |
| Acell, INC. | $30.19 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $20.11 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $18.47 | 2019 | |
| Baxter Healthcare | $17.96 | 2020 | |
| Astellas Pharma US INC | $15.26 | 2019 | |
| Portola Pharmaceuticals, LLC | $14.10 | 2019 | |
| Zimmer Biomet Holdings, INC. | $13.74 | 2019 | |
| Haemonetics Corporation | $13.65 | 2025 | Teg6s Hemostasis System |
| Smith+Nephew, INC. | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linda Ding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.